Dossier
web
review
Polycythemia Vera: 2024 Update on Diagnosis, Risk-Stratification, and Management
Key claim: This 2024 clinical update reviews current standards for diagnosing, risk-stratifying, and managing polycythemia vera, including JAK2 mutation testing and prognostic factors in MPN.
Abstract
Recent clinical review of PV diagnosis, risk stratification, and management including discussion of JAK2 mutation testing and prognostic factors in MPN.
Why this matters
This 2024 clinical update reviews current standards for diagnosing, risk-stratifying, and managing polycythemia vera, including JAK2 mutation testing and prognostic factors in MPN.